This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Xiaodong Yu in Cancer Treatment
Introduction
Xiaodong Yu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cancer treatment options. His innovative work focuses on the creation of novel pharmaceutical compounds that can potentially improve therapeutic outcomes for patients.
Latest Patents
Xiaodong Yu holds a patent for a 5-fluorouracil derivative, which is a crucial compound in cancer therapy. The patent details a derivative with a specific molecular structure, where Ra and Rb groups are alkoxy or fluorine-substituted alkoxy groups. This compound is designed to be used in the treatment of cancer, tumor diseases, and conditions caused by abnormal neovascularization in mammals. The patent also outlines methods for preparing this derivative and its applications in medicinal formulations.
Career Highlights
Throughout his career, Xiaodong Yu has demonstrated a strong commitment to advancing cancer treatment through innovative research. His work has led to the development of a unique compound that could enhance the effectiveness of existing cancer therapies. With a focus on improving patient outcomes, he continues to explore new avenues in pharmaceutical development.
Collaborations
Xiaodong Yu has collaborated with notable colleagues, including Wan Pang and Jiujiu Zhou. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medicinal chemistry.
Conclusion
Xiaodong Yu's contributions to cancer treatment through his innovative patent on 5-fluorouracil derivatives highlight the importance of research in developing effective therapies. His work exemplifies the potential of scientific innovation to address critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile